Pressemitteilungen

Title Content Date
immatics presents encouraging overall survival data from a phase 2 study in Advanced Colorectal Cancer at the ASCO Annual Meeting Tuebingen, June 1, 2012 – immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, today announced that its 04.06.2012
Ray of hope for millions of patients In Germany alone, around 4.5 million people suffer from the dry form of age-related macular degeneration, the most common cause of blindness in the industrialised world. 15.05.2012
Networking business and research The project, which will run for 37 months, starts on 1 April 2012 and has a total budget of EUR 3 million. 13.02.2012
European tool enables companies to open up markets BioRegio STERN Management GmbH is one of five project partners in BIOMAT-In. 06.02.2012
"We still have a lot to do" BioRegion STERN is one of the largest and most successful bioregions in Germany. 16.12.2011
Obsessed biotechnologists and Swabian SMBs The focus during the three-hour event attended by around 100 guests from political, business and research communities was on questions and answers rather than the anniversary itself. 16.12.2011
Metabolomic snapshot – one drop is enough Anyone looking to get a thorough check-up at the doctor's normally has to give quite a lot of blood. 08.12.2011
Tracking Killer Germs Faster CeCo Labs UG, founded as a spin-off from the University of Tübingen, has developed an internationally unique method for isolating bacterial cell walls. 23.11.2011
»We want more!« The transnational EU FASILIS project has come to a successful conclusion. 19.10.2011
A network packed with innovations and investment The STERN BioRegion encompasses biotechnology and medtech companies in the cities and regions of Stuttgart, Tübingen, Esslingen, Reutlingen and Neckar-Alb in Germany. 23.08.2011

Pages